Navigation Links
3-V Biosciences To Present at the Seventh Annual JMP Securities Healthcare Conference
Date:7/10/2012

MENLO PARK, Calif., July 10, 2012 /PRNewswire/ -- 3-V Biosciences, Inc., announced today that George Kemble, PhD, Chief Scientific Officer, will present at the upcoming JMP Securities Healthcare Conference at the Peninsula Hotel in New York City.  Dr. Kemble will provide an overview of 3-V, including a discussion of both its lead program targeting the fatty acid synthase (FASN) pathway for the treatment of chronic hepatitis C virus (HCV) infection and the company's discovery platform.  Dr. Kemble's presentation will take place on Friday, July 13 at 12:00pm.

FASN is a cellular enzyme with increased expression following infection with HCV and in several cancers.  First-generation FASN inhibitors have shown preclinical benefits in a variety of viral infections, including HCV, as well as in models of pancreatic, prostatic, breast and colorectal tumors, but their development has been hindered by poor bioavailability and systemic tolerability.  3-V has discovered and is advancing proprietary FASN inhibitors with pharmaceutical properties that overcome the shortcomings of earlier generations of inhibitors, and have the potential to become potent therapeutics for chronic HCV and other indications.

About 3-V Biosciences

3-V Biosciences, Inc. is a privately held biopharmaceutical company that discovers and develops antiviral therapeutics designed to have broad-spectrum activity, including efficacy against viruses resistant to other classes of antiviral drugs, and a high barrier to resistance.  The 3-V team applies an integrated approach with internal expertise in virology, biology, drug discovery and development to drive programs forward.  The company is located in Menlo Park, California.

For additional information on 3-V Biosciences, please visit www.3vbio.com.

Contact information Stephen R. Brady Chief Business Officer 650-561-8600


'/>"/>
SOURCE 3-V Biosciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Neurocrine Biosciences to Present at the Jefferies 2012 Global Healthcare Conference
2. Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug (IND) Application for CEP-32496, A Novel BRAF(V600E) Inhibitor
3. Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update
4. Neurocrine Biosciences Reports First Quarter 2012 Results
5. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
6. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
7. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
8. Insmed To Present At JMP Securities 7th Annual Healthcare Conference
9. Inovio Initiates H1N1 Universal Influenza Vaccine Clinical Trial Targeting Over-65 Population, Which Represents 90% of Flu Deaths
10. Anthera Pharmaceuticals to Present at the 7th Annual JMP Securities Healthcare Conference
11. Delcath To Present At JMP Securities Healthcare Conference On July 12
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/12/2020)... ... January 10, 2020 , ... Cytonus ... been selected to present at next week’s Biotech Showcase. Cytonus is a ... its proprietary Cargocyte™ next generation Adoptive Cellular Therapy (ACT) technologies which have ...
(Date:1/12/2020)... (PRWEB) , ... January 11, 2020 , ... New ... than a regular vacation and information on how to book an affordable option. , ... get away from the frenetic pace of everyday life, sight see and a try ...
(Date:1/10/2020)... ... January 10, 2020 , ... Braid.Health — ... and the healthcare industry — today announced the appointment of Connie Phelps as ... experience, working with health systems in sales and marketing leadership roles. Phelps was ...
Breaking Medicine Technology:
(Date:1/23/2020)... ... 23, 2020 , ... The American Heart Association (AHA), the leading voluntary health ... Ventura County Go Red for Women Luncheon will take place Friday, February 21, ... 500 residents are anticipated to attend the premier event designed to raise awareness and ...
(Date:1/23/2020)... , ... January 23, 2020 , ... ... RespirCare, LLC, a first-of-its-kind, full-service pulmonology clinic based in Tulsa, to provide patients ... agreement, MCNDOH patients will also have access to HGE Health’s digital symptom management ...
(Date:1/23/2020)... (PRWEB) , ... January 23, 2020 , ... Merger and ... in the fourth quarter of 2019, according to data from HealthCareMandA.com. The total is ... fourth quarter in 2018, when 65 deals were announced. , One deal disclosed a ...
(Date:1/23/2020)... (PRWEB) , ... January 23, 2020 , ... ... of providing programs and services that improve workforce resilience, is presenting at the ... serves as an advocate and resource for organizations that devote themselves to society’s ...
(Date:1/23/2020)... , ... January 23, 2020 ... ... engagement SaaS vendor announced their partner agreement with Healthpac, a trusted medical ... billing offices and medical offices an expanded offering. Healthpac’s customers can now ...
Breaking Medicine News(10 mins):